** Shares of biotechnology firm Windtree Therapeutics WINT.O down 8.30% at about $0.49
** CEO Craig Fraser to retire, effective Dec. 1
** Fraser to remain on the board as chairman
** Jed Latkin, current director, appointed as CEO
** Including session gains, stock had fallen 96.1% YTD
(Reporting by Nithyashree R B)
((NithyashreeRB@thomsonreuters.com;))